Exelixis Competitors and Similar CompaniesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Northwest Biotherapeutics.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | |
Founding Date | Founding Date 2003 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Bethesda, US HQ |
Employees | Employees 35037% increase | Employees 1721% increase |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 349.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $1.4m (FY, 2025) |
Net income | Net income ($194.9m) (FY, 2023) | Net income ($60.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 714m | Total funding raised $ 135.9m |
For sources of this data, please see the company profile
View Company Profiles
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View company